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Mechanism of aminoglycoside 3’-phosphotransferase type Illa: 
His188 is not a phosphate-accepting residue 
Paul R Thompson ‘, Donald W Hughes* and Gerard D Wright’ 
Background: The enzyme aminoglycoside 3’-phosphotransferase Type llla 
(APH(3’)-llla), confers resistance to many aminoglycoside antibiotics by 
regiospecific phosphorylation of their hydroxyl groups. The chemical mechanism 
of phosphoryl transfer is unknown. Based on sequence homology, it has been 
suggested that a conserved His residue, His1 88, could be phosphorylated by 
ATP, and this phospho-His would transfer the phosphate to the incoming 
aminoglycoside. We have used chemical modification, site-directed mutagenesis 
and positional isotope exchange methods to probe the mechanism of phosphoryl 
transfer by APH(3’)-llla. 
Results: Chemical modification by diethylpyrocarbonate implicated His in 
aminoglycoside phosphorylation by APH(3’)-llla. We prepared His + Ala 
mutants of all four His residues in APH(3’)-llla and found minimal effects of the 
mutations on the steady-state phosphorylation of several aminoglycosides. One 
of these mutants, His1 88Ala, was largely insoluble when compared to the wild- 
type enzyme. Positional isotope exchange experiments using y-[lsO]-ATP did not 
support a double-displacement mechanism. . 
Conclusions: His residues are not required for aminoglycoside phosphorylation 
by APH(3’)-llla. The conserved His1 88 is thus not a phosphate accepting 
residue but does seem to be important for proper enzyme folding. Positional 
isotope exchange experiments are consistent with direct attack of the 
aminoglycoside hydroxyl group on the y-phosphate of ATP 
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Introduction 
Hospital-acquired infections have become a particularly 
serious problem because of the widespread dissemination 
of antibiotic resistance genes. The Gram positive cocci of 
the genera Enterococcus and Staphyylococcus are among the 
more prevalent causes of these infections [l]. Entero- 
coccal infections are treated with a combination of 
aminoglycoside and B-lactam antibiotics, or with the 
glycopeptide vancomycin [Z]. These infections have 
become increasingly difficult to treat because of the 
selection of large numbers of antibiotic resistance deter- 
minants [3]. This increase in antibiotic-resistant organisms 
has brought into question the future usefulness of 
aminoglycosides and other antibiotics [4,5]. 
In general, aminoglycoside antibiotics are composed of a 
central Z-deoxystreptamine aminocyclitol ring which is 
linked to various aminosugars via glycosyl bonds (e.g., Fig. 
1). Bacterial resistance to the aminoglycosides occurs 
predominantly through a variety of enzyme-catalyzed 
processes [6]. These mechanisms involve the covalent 
modification of aminoglycosides by 0-phosphorylation, 
N-acetylation or 0-adenylation. These modifications are 
catalyzed by a superfamily of transferases, comprising 
greater than fifty individual enzymes [7,8]. Species of 
both the Enterococcus and Staphylococcus genera can harbor 
specific aminoglycoside-modifying isozymes, which cir- 
cumvent the bactericidal effects of these antibiotics [9]. 
One of these enzymes, the 3’-aminoglycoside phospho- 
transferase type IIIa (APH(3’)-IIIa), confers resistance to a 
broad spectrum of aminoglycosides including the 
clinically important drug amikacin [ 10,111. 
APH(3’)-IIIa catalyzes the transfer of the y-phosphate of 
ATP to the 3’ hydroxyl group of 4,6-disubstituted deoxy- 
streptamine aminoglycosides and to both the 3’- and 
5”-hydroxyls of 4,5-disubstituted deoxystreptamine 
aminoglycosides, such as neomycin, that possess available 
hydroxyl groups (Fig. 1) [1’2]. Six other classes of APH(3’)s 
have been identified and their protein sequences have 
significant homology in the carboxy-terminal region [8]. 
Three conserved motifs have been identified (Fig. 2) and, 
although their function is not known, Martin et a/.) [13] 
have speculated that, based on homology searches of 
protein databases, motif 2 is part of the nucleotide binding 
site, motif 3 is involved in aminoglycoside binding 
and motif 1 is directly involved in catalysis. Specifically, 
they postulated that the strictly conserved histidine in 
APH(3’) enzymes (His188 in APH(3’)-IIIa) may act as a 
phosphate-accepting residue, mediating the transfer of 
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HO 
Neomycin B 
HO 
Kanamycin A 
ATP ADP 
*-ospo 
7 
ATP ADP 
APH(3’)-Ma catalyzes the regiospecific 
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the y-phosphate of ATP to an aminoglycoside hydroxyl 
group via a phospho-enzyme intermediate (Fig. 3a) [13]. 
We have not found any steady-state kinetic evidence for a 
phospho-enzyme intermediate with APH(3’)-IIIa [14,15]. 
Thus, an equally plausible mechanism of phosphate 
transfer would be by the direct in-line transfer of the 
terminal phosphate of ATP to a specific aminoglycoside 
hydroxyl group (Fig. 3b) [ 16,171. A dissociative mecha- 
nism in which a hyper-electrophilic metaphosphate anion 
is generated is theoretically possible, but would be 
unprecedented. All known enzymatic phosphoryl transfers 
occur by associative mechanisms [ 171. 
Site-directed mutagenesis of His188 has been reported for 
the APH(3’)-II from Tn.5. Substitution of His188 with 
Figure 2 
Conserved motifs (1,2,3) in APH(3’) sequences. His1 88 is found in 
motif 1. Lys44 can be labeled with p-fluorosulfonylbenzoyl adenosine 1381, 
and thus contacts ATP The single-letter code for amino acids is used. 
residues, such as Ser and Tyr, or Leu [18], that are 
potential phosphate acceptors (but very poor phosphate 
donors), or by Gln [19] demonstrated the importance of 
this residue for conferring aminoglycoside resistance; for 
cells harboring a mutant enzyme, a dramatic decrease in 
minimal inhibitory concentrations for a number of 
aminoglycosides was observed. Assays of crude cell-free 
extracts on the Hisl88Gln mutant revealed a two-fold 
increase in the K, for ATP and a 35fold decrease in 
relative activity, but the enzyme was not purified [19]. 
To understand the mechanism of phosphoryl transfer for 
the rational design of inhibitors and/or new antibiotics, we 
have undertaken to delineate the chemical mechanism of 
phosphoryl transfer. The question of whether phosphate 
transfer occurs through a phospho-enzyme intermediate or 
by a direct in-line attack is complicated by the fact that 
the kinetic mechanism of APH(3’)IIIa is Theorell-Chance 
[14]. In this version of an ordered BiBi mechanism, ATP 
binds to the enzyme first and the aminoglycoside second; 
this is followed by release of the phospho-aminoglycoside 
and ADP. In such a mechanism the ternary complex is 
transparent in the steady state because product release is 
completely rate limiting, and as such the existence of a 
phospho-enzyme intermediate cannot be discounted. To 
discern between double-displacement (phospho-enzyme) 
and direct-attack associative mechanisms, and to eluci- 
date the possible role of His188 in catalysis, we have 
approached the problem in two ways. First, we examined 
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Figure 3 
Possible mechanisms of phosphate transfer 
catalyzed by APH(3’Wa. The reaction may 
proceed (a) by a double-displacement 
mechanism in which a phospho-His 
intermediate is formed or(b) by direct in-line 
transfer of the terminal phosphate of ATP to a 
specific aminoglycoside hydroxyl group. 
r ( a)
ADp.o-p-o-: NvNH 
v’l 
0. 
11 
ON NH; 
the roles of the His residues in APH(3’)-IIIa by chemical 
modification and site-directed mutagenesis. Second, we 
addressed the question of the route of phosphoryl transfer 
(Fig. 3a versus 3b) by the positional isotope exchange 
(PIX) technique of Midlefort and Rose [20,21]. These 
experiments provide evidence that neither His188 nor any 
other His residue in the enzyme is required for catalysis 
and that the most likely mechanism is direct attack of the 
aminoglycoside hydroxyl group on the -y-phosphate 
of ATP 
Results 
Inactivation of APH(3’)-llla by chemical modifying agents 
We initially explored the roles of several different amino 
acid residues in catalysis by a survey of the susceptibility of 
APH(3’)-IIIa to various chemical modifying agents 
(Table 1). The enzyme showed broad sensitivity to com- 
pounds modifying carboxyl and thiol groups as well as Tyr 
and Arg residues. The susceptibility to diethylpyro- 
carbonate (DEPC) suggested a possible role for His 
residues in catalysis [Z]. Inactivation by DEPC was 
largely overcome by the subsequent addition of hydroxyl- 
amine (not shown). This result, and the observation that 
DEPC treatment caused an increase in absorbance at 
242 nm but not at 278 nm, supported the notion that His is 
modified rather than Tyr, which is also a possible target for 
this agent [ZZ]. Rates of inactivation were best fit to a 
double exponential decay model, suggesting that more 
than one residue was modified and that these 
modifications had different effects on the enzymatic rate 
(Table 2). This was confirmed by stoichiometric 
measurements, which indicated that approximately three 
His residues were modified (Table 2). 
Table 1 
Chemical modification of APH(3’)-llla. 
Reagent Target Concentration Activity 
hM) Wo) 
Control, pH 7.5 100 
N-Ethylmaleimide CYS 0.5 47 
p-Chloromercuribenzoic acid CYS 0.5 3 
Diethylpyrocarbonate His, Tyr, Cys 10 2 
1 -Ethyl-3- C-term COO-, 2.5 23 
(3-dimethylaminopropyl)- Asp, Glu 
carbodiimide 
Tetranitromethane Tyr 2.5 1.8 
Control, pH 8.0 100 
Phenylglyoxal Arg 2.5 10 
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Table 2 
Inactivation of APH(3’)-llla by DEPC. 
Enzyme Stoichiometry Rates of inactivation 
Rate 1 Rate 2 
Wild type 3.4 0.17 f 0.054 0.010 f 0.011 
His78Ala 2.3 0.49 f 0.156 -0.0026 zk 0.0063 
His82Ala 2.9 2.12+ 1.75 0.032 f .0256 
His1 23Ala 3.3 0.36kO.12 0.0049 f 0.0067 
His1 88Ala 2.0 0.75 f 0.047 0.0085 f 0.0087 
His+Ala mutagenesis of APH(3Wlla 
There are four His residues in APH(3’)-IIIa: His78, 
His82, His123 and His188. All four were individually 
mutated to Ala, and the mutant proteins were 
overexpressed in Escherichia coL and purified. The 
mutant enzymes were first characterized by steady-state 
kinetic methods (Table 3). None of the mutants demon- 
strated dramatic deviation from wild-type behavior, and 
V/K was essentially unchanged. Since His188 is 
absolutely conserved in all known APH(3’) sequences 
and had been proposed to be important in catalysis, we 
determined the accurate molecular mass by electrospray 
mass spectrometry to ensure that the kinetic results were 
not due to contamination by native enzyme. The mass 
was determined to be 30 778 Da, demonstrating the 
integrity of the His188Ala mutant (predicted mass: 
30 779 Da, less the amino-terminal Met). We did, how- 
ever, observe that the yield of purified Hisl88Ala protein 
was very poor (< 1 mg 1-l of cell culture compared to 
>50 mg for the wild-type enzyme). SDS-PAGE and 
Western analysis of the soluble and insoluble fractions 
following cell lysis revealed that the His188Ala mutant 
was highly expressed but was found mostly as an 
inactive, precipitated form (Fig. 4). 
All four His mutant proteins were DEPC sensitive, and 
had similar inactivation kinetics (Table 2). The stoichio- 
metries of inactivation were also similar, but suggest that 
His123 is not as readily modified as the others and thus is 
probably buried within the folded protein. 
PIX Experiments 
We performed PIX experiments with wild-type APH(3’)- 
IIIa using ATP specifically enriched with 180-labeled 
phosphate in the -y-position (Fig. 5). The experiment was 
performed at saturating concentrations of r-[180]-ATP, 
with either APH(3’)-IIIa alone, or APH(3’)-IIIa in the 
presence of tobramycin, a competitive inhibitor of 
APH(3’)-IIIa that lacks the accepting 3’-hydroxyl group. 
The 31P NMR spectra corresponding to the p and y 
phosphate of ATP remain unchanged under all conditions 
tested (see Fig. 6). The formation of a transient phospho- 
enzyme intermediate would have resulted in the 
appearance of new peaks downfield from those corre- 
sponding to the y phosphate and upfield from the 
P-phosphate peaks [23]. The lack of a PIX is inconsistent 
Table 3 
Steady state kinetic parameters for wild type and mutant APH(3Yllla proteins. 
Wild Typea 
Substrate K, ($4 kc, (s-‘1 Ki WA) 
ATP 27.7 f 3.7 1.76 + 0.08 
Kanamycin A 12.6 f 2.6 1.79 f 0.09 6.38 f 1.67 
Neomycin B 7.72 f 0.9 2.08 + 0.07 2.65 f 0.59 
Amikacin 245 f 27 2.46 f 0.11 ND 
His82Ala 
K, (I.LM) k,, b’ ) Ki b-d) 
ATP 12.17f2.5 0.35 + 0.01 
Kanamycin A 2.44 + 0.52 0.35 f 0.01 6.7 f 2.8 
Neomycin B 1.31 f 0.20 0.69 f 0.01 
Amikacin 93.1 f 10 0.50 f 0.01 
His1 88Ala 
K, (cLM) k,, (s-‘1 Ki (mM) 
ATP 33.5 f 5.9 3.75 + 0.16 
Kanamycin A 17.4k1.7 3.36 f 0.07 
Neomycin B 3.2 f 0.7 1.20 Ib 0.05 2.74 j: 0.88 
Amikacin 184+30 2.04 f 0.09 
aKinetic parameters for wild type APH(3’)llla are reproduced from 1111. 
K, ($4 
10.9f 1.8 
5.1 f 1.6 
27.0 f 5.1 
206 fl3 
K, (PM) 
11.6+1.8 
0.92 f 0.2 
0.29 + 0.13 
llOf13 
His78Ala 
kcat 6’ ) 
0.66 f 0.01 
0.67 f 0.04 
2.46 + 0.18 
1.74 & 0.04 
His1 23Ala 
km1 (s-l ) 
0.571 f 0.02 
0.49 f 0.01 
0.83 f 0.01 
0.87 f 0.03 
Ki (mM) 
1.68 f 0.86 
1.84 + 0.58 
Ki hM) 
5.03 f 2.82 
6.95 f 3.13 
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Figure 4 
Wild type His1 88Ala 
His1 88Ala APH(3’)-llla is expressed at high levels but is largely 
insoluble compared to the wild-type protein. The insoluble (Pl) and 
soluble (Sl) fractions from total cell lysates were separated by 
centrifugation. Proteins (2 Fg) were applied to an SDS-polyacrylamide 
gel (15 O/o), electroblotted onto nitrocellulose and probed with rabbit 
anti-APH(3’)llla. Western blots were visualized by incubation with 
alkaline-phosphatase-conjugated donkey-anti-rabbit IgG and 
developed with 5-bromo-4-chloro-3indolylphosphate-p-toluidine 
saltlnitroblue tetrazolium chloride. A faint band in the His1 88Ala Sl 
fraction can be seen in the original blot. 
with the hypothesis that phosphate transfer is mediated 
by a phospho-enzyme intermediate. 
Discussion 
The emergence of drug-resistant bacteria, especially 
multiply-resistant Enterococci and Staphylococci, is a 
major concern for health care [1,24]. As there is a 
shortage of new antibiotics to fight infection with these 
bacteria, the redesign of available antibiotics or the 
design of inhibitors of bacterial antibiotic-resistance 
mechanisms are likely to be important. Both of these 
methodologies will be facilitated by a thorough under- 
standing of the resistance mechanisms involved. In the 
case of the aminoglycoside class of antibiotics, the high 
prevalence of enzymes that mediate resistance via 
phosphorylation of the drugs and the lack of detailed 
mechanistic data has led us to study APH(3’)-IIIa [ 111. 
The apparent paradox presented by the broad specificity 
of APH(3’)-IIIa [ll], in contrast to its high regio- 
specificity [12], suggests that it would be a good model 
for the study of an aminoglycoside phosphorylation. 
Classical dead-end and product-inhibition analysis in the 
steady state, as well as supporting evidence in the form of 
isotope and viscosity effects, all confirm that APH(3’)-IIIa 
operates by a Theorell-Chance kinetic mechanism 
[14,15]. In this mechanism, ATP binds first, the 
aminoglycoside then enters, is phosphorylated and then 
released, followed by rate-limiting dissociation of ADP. 
Although a ping-pong kinetic mechanism is generally 
diagnostic of a double-displacement (phospho-enzyme) 
mechanism, the kinetic mechanism of APH(3’)-IIIa is 
nonetheless consistent with both direct nucleophilic 
attack of the aminoglycoside hydroxyl group on ATP and 
a phospho-enzyme double-displacement mechanism. 
Although no direct evidence for either mechanism had 
been presented, the presence of an invariant His residue 
in all known APH(3’) enzymes suggested the possibility 
that this residue participates in catalysis, perhaps as a 
phosphate-accepting residue [ 131. This suggestion was 
proposed, in part, because the sequence His-Xaa-Asp is 
conserved in several nucleotide-binding proteins such as 
adenylate kinase, protein kinases and elongation factors 
[ 131. This sequence similarity can now be reexamined in 
the light of many more amino-acid sequences and of X-ray 
crystal structures of some of the aforementioned proteins. 
For example, the His-Xaa-Asp triad [13], does not appear 
to have a role in nucleotide binding, based on the three- 
dimensional structures of adenylate kinase, EF-Tu and 
EF-G [25-271. 
Figure 5 
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Positional isotope exchange by an enzyme using a double- 
displacement mechanism. In 31P NMR of the complex of labeled ATP 
and enzyme, the formation of the transient phospho-enzyme 
intermediate would result in the appearance of new peaks downfield 
from those corresponding to the y phosphate and upfield from the 
P-phosphate peak. 
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Figure 6 Figure 7 
(a) 
0)) 
31P NMR of y-[‘so]-ATP complexed with APH(3’)-llla indicates that 
the formation of a phospho-enzyme intermediate is not involved in the 
catalytic mechanism of the enzyme. The figure shows 31P NMR with 
(a) standard v-[~*O]-ATP, (b) Y.[~*O]-ATP + APH(3’)-llla and (c) 
y-[‘so]-ATP + APH(3’)llla + tobramycin (20 JLM). APH(3’)-llla 
(0.1 nmol) f tobramycin was incubated for 15 min with -y-[‘*O]-ATP 
(0.4 mM) at 37 “C. Approximately 40 o/, (158 nmol) of the available 
ATP was expected to have been turned over during incubation with 
APH(3’)llla. The linewidths of the sharpest peaks in the spectra are 
approximately 1.5 Hz. Based on a digital resolution of 0.47 Hz per 
point a minimum peak separation of 1 .O Hz is possible. The data was 
processed with a 1 .O Hz line broadening enabling the observation of 
peaks shifted downfield by 4.7 Hz, indicative of rs03P1e0, relative to 
the P’sO, resonance. No rs02P1s0, species was detected in the 
region approximately 8.0 Hz downfield of the PlsO, 
APHWbIIIa 
CAPK 
CDK2 
IRK 
ERK2 
CSK 
SRC 
ARL 
Hlee GDLGDSN 
Y164 RDLKPEN 
Hlas RDLKPQN 
H1157 RDLAARN 
H147 RDLKPSN 
Hsll RDLAARN 
H197 RDLRAAN 
H994 RDLRAAN 
Ha31 RDLAARN 
Partial alignment of conserved kinase sequences shows conserved 
His, Glu and Asn residues. The single-letter code for amino acids is 
used. Swiss-Pro database accession numbers are: APH(3’)-llla, 
PO0554; human CAMP-dependent protein kinase (cAPK), P22694; 
human cyclin-dependent protein kinase 2 (CDK2), P24941; human 
insulin receptor precursor (IRK), PO621 3, human MAP kinase ERKP, 
P28482; human CSK, P41240; human c-SRC, P12931; human 
c-YES, P07947; human c-ABL, PO051 9. 
The motif 1 sequence His-Xaa-Asp-Xaa-Xaa-Xaa-Xaa-Asn 
was previously noted in a few eukaryotic protein kinases 
[13,28] and can now be identified in many different 
protein kinases (Fig 7). The crystal structures of the 
Ser/Thr cyclin-dependent kinase 2 (Cdk2) [29], the 
Ser/Thr MAP kinase ErkZ [30], and the tyrosine kinase 
domain of the human insulin receptor (IRK) [31] have 
recently been solved and shed some light on the role of 
this conserved sequence in protein kinases. The conserved 
His residue does not seem to have a direct role in catalysis. 
But, based on the structure and proposed mechanism of 
the CAMP-dependent protein kinase (cAPK), which lacks 
the conserved His, it has been suggested that the 
conserved Asp residue acts as a general base for 
deprotonation of the nucleophilic hydroxyl group and that 
the conserved Asn participates in an H-bond network 
required for Mgz+ coordination [32]. This sequence 
similarity suggests that the active site of APH(3’)-IIIa may 
share many characteristics of the protein kinase structures. 
As a first step towards determining the mechanism of 
APH(3’)-IIIa catalysis, we have explored the role of His 
residues. Chemical inactivation experiments suggested a 
role for COO- groups, Tyr, Arg, possibly Cys, and His. 
The sensitivity of APH(3’)-IIIa to the His-modifying 
agent DEPC was complex, and rate and stoichiometry 
experiments clearly demonstrated that more than one His 
residue are modified. Substrate-protection experiments 
were attempted but showed variable results, possibly 
because of interactions with DEPC. Chemical 
modification experiments are, however, notoriously 
difficult to interpret, largely due to the indiscriminate 
nature of the reactive agents. 
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To effectively dissect the possible role(s) of the four His 
residues of APH(3’)-IIIa in catalysis, we turned to site- 
directed mutagenesis. Mutagenesis of all four His residues 
individually to Ala proved highly informative. Neither 
His78 nor His82, which are not conserved among other 
APH(3’) enzymes, were important for enzyme function. 
The His+Ala mutants were still DEPC sensitive and did 
not have dramatically perturbed steady-state kinetics. 
His123, which is conserved in all but the class Via and 
VIIa 3’-aminoglycoside phosphotransferases [8], was also 
not critical for APH(3’)-IIIa activity. His188 is conserved 
among all APH(3’) enzymes, but again mutation to Ala 
had little effect on activity or DEPC sensitivity. There 
was, however, a dramatic effect on the recovery of active, 
soluble enzyme when His188 was replaced by Ala. This 
demonstrates that His188 is not required for catalysis, and 
is therefore not a phosphate accepting residue, but is 
probably critical for efficient protein folding. This result is 
also consistent with the homology to protein kinases 
where the conserved His residue does not appear to 
directly participate in catalysis. 
Characterization of the His-Ala mutants unequivocally 
demonstrated that His residues are not important for 
APH(3’)-IIIa activity. Thus, we could conclude that the 
catalytic mechanism does not involve a phospho-His 
intermediate, but the possibility still existed that a 
phospho-enzyme intermediate involving another residue, 
(e.g., phospho-Asp, Glu or Cys), was involved. We chose to 
explore this possibility by using the PIX methodology of 
Midlefort and Rose [ZO]. Incubation of the enzyme with 
y-[r80]-ATP followed by formation of a phospho-enzyme 
intermediate should permit the scrambling of ‘*O from the 
P-y-bridge to a non-bridge position two out of three times 
assuming the likely, ready exchange of oxygen between 
these positions (Fig. 5). This exchange is readily detectable 
by 31P NMR [23]. No PIX was observed with APH(3’)-IIIa, 
even when the enzyme was incubated with the 3’-deoxy 
aminoglycoside, tobramycin, to give a non-productive 
ternary complex. These results are consistent with direct 
in-line attack of the aminoglycoside nucleophilic OH on 
the y-phosphate of ATP (Fig. 3b) and are inconsistent with 
formation of a phospho-enzyme intermediate. 
Significance 
We have shown that His residues do not have a role in 
APH(3’)-IIIa catalysis and that the reason that His188 
is conserved among all APH enzymes may be because it 
is required for proper protein folding. The fact that 
many protein kinases also share the HXDXXXXN 
motif, and that the conserved His residue is not 
important in the catalytic mechanism of these enzymes, 
raises the tantalizing possibility that APHs and protein 
kinases share a common mechanism and structure. 
This hypothesis can be tested through further site- 
directed mutagenesis studies and structural experiments. 
It is also tempting to speculate that a common ancestral 
hydroxyl-group kinase may have existed. 
The PIX experiments support a direct-displacement 
mechanism for the phosphoryl transfer reaction. The 
mechanism does not require formation of a phospho- 
enzyme intermediate. Thus, analogs that mimic the 
pentacoordinate transition state shown in Figure 3b 
should be good inhibitors of the enzyme and could be 
therapeutically useful. There is no good reason that 
such compounds would have to be aminoglycosides 
themselves, and thus it may be possible to develop a new 
class of aminoglycoside-kinase inhibitors. 
Materials and methods 
Chemicals 
Kanamycin A, neomycin B, amikacin, tobramycin and pyruvate 
kinasellactate dehydrogenase were obtained from Sigma (St. Louis, 
MO). ATP was obtained from Boehringer Mannheim (Laval, Quebec, 
Canada). H,‘sO (97.8 atom%) was obtained from lsotec (Miamisburg, 
OH). KH,PlsO, was synthesized by the method of Risley and Van 
Etten [33]. [y-180]-ATP was prepared by reaction of KH,P’sO, with 
ADP-morpholidate as previously described 134). 
Site-directed mutagenesis of His 78, 82, 123, and 188 to Ala 
The His1 88 to Ala mutant was generated by Kunkel methodology [35] 
using the oligonucleotide 5’-CTCCCAGGTCGCCGGCGGAAAAGA- 
CGAGCTC-3’. The mutated gene was subcloned into PET-22b(+) 
(NovaGen, Madison, WI) using the restriction enzymes Ncfel and 
Hindlll to generate the expression construct pAPHHl88A. 
Mutagenic oligonucleotides 5’-CATGCCGTTCAAAGGCCAGGACCT- 
TTGG-3’, 5’-GCTCCAGCCATCAGCCCGTTCAAAGTGC-3’, and 
5’-CGATATGTCGATCGAGGCAAAGAGCCTGATGC-3’ were used to 
generate the His to Ala mutants 78, 82 and 123, respectively, by the 
megaprimer PCR mutagenesis method [36]. In all cases, a megaprimer 
was amplified from pETSACG1 using the mutagenic oligonucleotide 
and our 5’ PCR primer 1111 in the polymerase chain reaction (PCR). In 
subsequent PCR reactions mutagenic megaprimers were isolated and 
used to amplify the full length gene using our 3’ PCR primer. The 
isolated fragments were digested with Noel and HindIll and ligated 
into similarly cut PET-22b(+). Presence of the desired mutations in 
pETH78A and pETH82A constructs were confirmed by sequencing at 
The Central Facility of the Institute for Molecular Biology and 
Biotechnology, McMaster University. Presence of the desired mutation 
in pETHl23A constructs was confirmed by the incorporation of a silent 
Paul site in the mutagenic oligonucleotide. All confirmed constructs 
were subsequently sequenced in their entirety to ensure that no 
undesired mutations had resulted during PCR amplification. 
Purification of mutant APH(3’)-llla proteins 
Mutant APH(3’)-llla proteins were purified as previously described [l 11. 
Further purification was required for mutants His82Ala and His1 88Ala. 
Pure protein was obtained by application of fractions to a Superdex 200 
(HRl O/30) column at a flow rate of 0.4 ml min-’ in 50 mM Tris HCI 
pH 8.0, 1 mM EDTA and 200 mM NaCI. Enzyme activity was analyzed by 
coupling the release of ADP to a pyruvate kinase/lactate dehydrogenase 
reaction and the initial rates obtained were used to determine the steady 
state kinetic parameters, as described in McKay et a/. [l 11. 
Western analysis 
Cultures (200 ml) of E. co/i BL 21 (DEB)/pETSACGl and E. co/i BL 
21 (DE3)/pAPHH188A were grown from overnight innocula at 37 “C 
(250 rpm) and induced as previously described [ll]. Cells were 
harvested by centrifugation, lyzed in a French pressure cell and the 
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lysate fractionated by centrifugation (12 000 x g for 20 min). The 
insoluble pellet, Pl, was resuspended in 5 ml of lysis buffer (50 mM 
Tris HCI pH 7.5, 5 mM EDTA, 200 mM NaCI, 1 mM PMSF, 0.1 mM DTT 
and 0.1 o/, SDS). The protein concentration of both the supernatant 
(Sl) and Pl fractions were determined and identical amounts of total 
protein (2 p,g) were applied to an SDS-polyacrylamide gel (15 o/o). 
Proteins were electroblotted onto nitrocellulose and probed with rabbit 
anti-APH(B’)-llla polyclonal antibody (McKay and Wright, unpublished 
data). Blots were then incubated with an alkaline-phosphatase- 
conjugated donkey-anti-rabbit (IgG) antibody (Jackson lmmuno 
Research) and developed using 5-bromo-4-chloro-3-indolylphosphate- 
p-toluidine salt/nitroblue tetrazolium chloride (GIBCOIBRL). 
Survey of chemical modifiers 
The effect on aminoglycoside kinase activity after treatment of wild-type 
APH(3’)llla with N-ethylmaleimide (500 JLM), p-chloromercuribenzoic 
acid (500 PM), phenylglyoxal (2.5 mW, 1 -ethyl-3(3- 
dimethylaminopropyl)-carbodiimide (2.5 mM), DEPC (10 mM), and 
tetranitromethane (2.5 mM) was determined as follows. Typically, 
inactivations were performed in 50 mM HEPES pH 7.5, 10 mM MgCI, 
and allowed to proceed for 1 h at 37 “C after which the chemical 
modifier was removed by passage through a Sephadex G-10 spin 
column (0.4 ml) and aliquots assayed for enzymatic activity. Treatment 
of APH(3’)-llla with phenylglyoxal was performed in 100 mM sodium 
bicarbonate pH 6.0. The inactivation with tetranitromethane was 
performed at room temperature. 
The rate and stoichiometry of inactivation of APH(3’)-llla by DEPC 
were studied in greater detail. Activity remaining was plotted against 
time and analyzed by nonlinear least squares fitting of equation 1, 
A = A,, e-kit + A,se-kz+ (1) 
where A is enzyme activity, A, is initial activity k,and k, are rate 
constants and t is time. The stoichiometry of inactivation was determined 
using a final DEPC concentration of 5 mM. Wavelength scans were 
obtained after a 1 h incubation with DEPC at room temperature and the 
change in absorbance at 242 nm was determined. The stoichiometry of 
inactivation was determined using an extinction coefficient of 
3200 M-l cm-’ [371. 
Positional isotope exchange 
[y-lsOl-ATP (400 FM) was incubated for 15 min in 50 mM HEPES 
pH 7.5, 15 mM MgCI,, 13 O/o D,O either alone or with APH(3’)-llla 
(0.1 nmoles) or with enzyme and 20 PM tobramycin. APH(3’)-llla 
activity was quenched by the addition of EDTA to a final concentration 
of 40 mM and 100 pl of Ccl,. The pH was then adjusted to 9.2. The 
31P NMR spectra were recorded on a Bruker Avance DRX-500 
spectrometer at 202.456 MHz using a 5 mm broadband inverse probe 
equipped with a triple axis gradient capability. The spectra were 
acquired in 36 500 scans over a 7.716 KHz spectral width in 32 K 
data points (1.062 s acquisition time). A 31P 90” pulse width of 9.0 )LS 
was then used. The relaxation delay was set to 0.5 s. Sample 
temperature was maintained at 30 ‘C by a Bruker Eurotherm B-VT 
2000 variable temperature apparatus. The free induction decays were 
processed using exponential multiplication (line broadening: 1 .O Hz) 
and zero filled to 64 K before Fourier transformation. Chemical shifts 
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